Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upadacitinib and Ustekinumab vs Intensified Ustekinumab in Crohn's Disease
NCT06520397Phase 4Recruiting
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- Jul 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of upadacitinib in Crohn's disease, sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Started Jul 2024; status: recruiting.
02
Drugs
upadacitinib
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT06520397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06520397.